>중동 및 아프리카 혈장 분획 시장, 제품 유형(면역글로불린, 응고 인자 농축액, 알부민, 프로테아제 억제제 및 기타 제품), 응용 분야(신경학, 면역학, 혈액학, 중환자 치료, 폐의학, 혈액 종양학, 류마티스학 및 기타), 처리 기술(이온 교환 크로마토그래피, 친화성 크로마토그래피, 냉동 보존, 한외 여과 및 정밀 여과), 모드(현대 혈장 분획 및 전통적 혈장 분획), 최종 사용자(병원 및 진료소, 임상 연구 실험실 학술 기관 및 기타), 유통 채널(직접 입찰, 제3자 유통 및 기타), 국가(남아프리카, 사우디 아라비아, UAE, 이스라엘, 이집트 및 중동 및 아프리카의 나머지 지역) 산업 동향 및 2028년까지의 예측.
시장 분석 및 통찰력: 중동 및 아프리카 플라스마 분획 시장
중동 및 아프리카 플라스마 분획 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 4.9%의 CAGR로 성장하고 있으며 2028년까지 1,072.80백만 달러에 도달할 것으로 예상된다고 분석합니다.
혈장은 혈액 성분으로, 혈장교환술을 통해 전혈에서 추출되며 다양한 치료 및 의료 용도로 사용됩니다. 인간 혈장은 수많은 다른 단백질의 공급원이지만, 이러한 단백질 중 치료용 혈장 제품을 생산하는 데 유용한 것은 일부에 불과합니다. 혈장에서 이러한 단백질을 분리, 추출 및 정제하는 과정을 분획 공정이라고 합니다. 혈장에서 추출한 단백질은 주로 면역글로불린, 응고 인자 농축물, 알부민, 프로테아제 억제제 등과 같은 종류로 분류됩니다.
중동 및 아프리카 혈장 분획 시장은 전 세계 호흡기 질환 증가, 혈액 관련 질환을 앓는 고령 인구 증가, 면역글로불린 사용 증가와 같은 요인으로 성장하고 있습니다. 혈장 요법이나 혈장 파생물을 사용해야 하는 희귀 질환의 증가도 시장 성장의 주요 요인으로 작용합니다. 연구 개발에 대한 투자 증가도 중동 및 아프리카 혈장 분획 시장에 붐을 일으켰습니다.
이 플라스마 분획 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 창출, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 기회 분석을 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.
중동 및 아프리카플라스마 분획 시장 범위 및 시장 규모
Middle East and Africa Plasma Fractionation Market, By product type (immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors and other products.), application (neurology, immunology, hematology, critical care, pulmonology, hemato- oncology, rheumatology and others), processing technology (Ion- exchange chromatography , affinity chromatography, cryopreservation, ultrafiltration and microfiltration), mode(modern plasma fraction and traditional plasma fractionation), End user (Hospitals & clinics, clinical research laboratories academic institutions and others), Distribution channel (into direct tenders, third party distribution and others). The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. On the basis of product type, the plasma fractionation market is segmented into immunoglobulins, coagulation factor concentrate, albumin, protease inhibitors and other products. Further, the Immunoglobulins have been segmented further into intravenous immunoglobulins, subcutaneous immunoglonbulins and others. Coagulation factor concentrates are further subsegmented into factor VIII, Factor CI, Von willebrand factor, Prothrombin complex concentrate, fibrinogen concentrates and factor XII. In 2021, immunoglobulin has the largest market share owing to the factors such as the high number of health benefits associated with immunomodulatory actions.
- On the basis of application, the plasma fractionation market is segmented into neurology, immunology, hematology, critical care, pulmonology, hemato- oncology, rheumatology and others. In 2021, Immunology has the largest market share owing to the factors such as increasing usage of plasma proteins in the treatment of immune deficiencies.
- On the basis of processing technology , the plasma fractionation market is segmented into Ion- exchange chromatography , affinity chromatography, cryopreservation, ultrafiltration and microfiltration. In 2021, Ion- exchange chromatography has the largest market share owing to the factor such as the high purification capability using ions by removing inorganic substances.
- On the basis of mode, the plasma fractionation market is segmented into modern plasma fraction and traditional plasma fractionation. In 2021, modern plasma fractions has the largest market share owing to the factors such as the employing the state of art equipment and production facilities for the plasma fractionation process.
- On the basis of End User, the plasma fractionation market is segmented into Hospitals & clinics, clinical research laboratories academic institutions and others. In 2021, hospitals & clinics has the largest market share due to improving infrastructure and health care facilities provided by hospitals, along with increasing off- label use of plasma fractionated products in hospitals to treat various diseases..
- On the basis of Distribution channel, the plasma fractionation market is segmented into direct tenders, third party distribution and others . In 2021, direct tenders has the largest market share due to. Increasing distribution through direct tenders from the manufacturers to the health care workers.
Middle East and AfricaPlasma Fractionation Market: Country Level Analysis
Middle East and Africa Plasma Fractionation Market is analysed and market size information is provided by country, Type (Bioinsecticides, Biofungisides, Bionematicides, Bioherbicides and Others), Source (Microbials, Biochemical and Insects), Form (Dry and Liquid), Application (Foliar Application, Fertigation, Soil Treatment, Seed Treatment and Other), Category (Agriculture and Horticulture) and Crops as referenced above.
The countries covered in the Middle East and Africa Plasma Fractionation Market report are South Africa, Saudi Arabia, UAE, Israel, Egypt and rest of middle east and africa
South Africa is dominating in the Middle East and Africa Plasma Fractionation Market with the highest CAGR as the region has more awareness about the extensive benefits of the plasma.
Saudi Arabia is dominating in the Middle East and AfricaPlasma Fractionation market due to increase in the demand for Plasma Fractionation and growing concern over the human health.
UAE is dominating the market with the highest share due to the geriatric population and immune deficiency diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africabrands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Demand of Plasma Fractionation in Agriculture
Middle East and AfricaPlasma Fractionation Market also provides you with detailed market analysis for every country growth in industry with sales, components sales, impact of technological development in Plasma Fractionation and changes in regulatory scenarios with their support for the Plasma Fractionation Product market. The data is available for historic period 2012-2018.
Competitive Landscape and Middle East and AfricaPlasma Fractionation Market Share Analysis
중동 및 아프리카 플라스마 분획 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 인도의 입지, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 포함됩니다. 위에 제공된 데이터 포인트는 중동 및 아프리카 플라스마 분획 시장과 관련된 회사의 초점에만 관련됩니다.
혈장 분획 시장의 주요 기업으로는 SL 혈장, Grifols SA, Octapharma, Kendrion SPA, BPL Inc, Sanquin, Biotest AG, LFB SA, Japan Blood products organization, china biologics product Holdings Inc.,, Green Cross corp, Shanghai Raas, Takeda pharmaceutical company limited, Bioproducts laboratory Ltd, Novasep Inc, Pall corporation, Kabafusion, Sichuan Yuanda shuyang pharmaceutical Co., ltd, Bharat Serums and Vaccines Limited, SK 혈장, Centurion pharma, Ntas biopharmaceuticals, Merck KgAa, Boccard 및 ADMA biologics 등이 있습니다.
전 세계 여러 회사에서 다양한 제품 출시를 시작하면서 중동과 아프리카의 플라스마 분획 시장 성장도 가속화되고 있습니다.
예를 들어,
- 2020년 4월, 그리폴스는 전 세계 광견병 환자 치료에 도움이 되는 혈장 분획 시장에서 광견병 면역글로불린인 Hyper RAB용 3ml 바이알을 출시했습니다.
시장 참여자들의 협력, 합작투자 및 기타 전략은 플라스마 분획 시장에서 회사의 입지를 강화하고 있으며, 이는 조직의 성장 속도에 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PRODUCTION FACILITIES FOR BLOOD PLASMA:
4.2 SUPPLIERS OF PROCESS LINES FOR PLASMA FRACTIONATION
4.2.1 RAW MATERIAL PROCUREMENT
4.2.2 MANUFACTURING
4.2.3 MARKETING & DISTRIBUTION
4.2.4 END-USERS
5 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: REGULATORY
5.1 THE U.S.
5.2 INDIA
5.3 EUROPE
5.4 BRAZIL
5.5 SOUTH AFRICA
6 MARKET OVERVIEW
6.1 3.1 DRIVERS
6.1.1 3.1.1 INCREASE IN RARE DISEASES THAT REQUIRES USE OF PLASMA THERAPY OR PLASMA DERIVATIVE
6.1.2 RISE IN RESPIRATORY DISEASES ACROSS THE WORLD
6.1.3 INCREASE IN AGING POPULATION WITH BLOOD-RELATED AILMENTS
6.1.4 INCREASE USAGE OF IMMUNOGLOBULIN
6.2 RESTRAINTS
6.2.1 GROWING USAGE OF RECOMBINANT PROTEIN PRODUCTS
6.2.2 STRINGENT GOVERNMENT REGULATIONS REGARDING PLASMA THERAPY
6.2.3 RISK OF QUALITY AND SAFETY
6.3 OPPORTUNITIES
6.3.1 INCREASE IN PLASMA COLLECTION CENTRES
6.3.2 UNHEALTHY LIFESTYLE POSSESS SERIOUS INFLAMMATION RISK
6.3.3 ADVANCEMENT IN TECHNOLOGIES
6.4 CHALLENGES
6.4.1 SHORTAGE OF PLASMA PROTEINS
6.4.2 HIGH COST OF PLASMA THERAPY
7 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
7.5 CONCLUSION
8 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 IMMUNOGLOBULINS
8.2.1 INTRAVENOUS IMMUNOGLOBULINS
8.2.2 SUBCUTANEOUS IMMUNOGLOBULINS
8.2.3 OTHER IMMUNOGLOBULINS
8.3 COAGULATION FACTOR CONCENTRATES
8.3.1 FACTOR IX
8.3.2 FACTOR VIII
8.3.3 FIBRINOGEN CONCENTRATES
8.3.4 PROTHROMBIN COMPLEX CONCENTRATE
8.3.5 VON WILLEBRAND FACTOR
8.3.6 FACTOR XIII
8.4 ALBUMIN
8.5 PROTEASE INHIBITORS
8.6 OTHER PRODUCTS
9 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 IMMUNOLOGY
9.3 HAEMATOLOGY
9.4 CRITICAL CARE
9.5 NEUROLOGY
9.6 PULMONOLOGY
9.7 HAEMATO-ONCOLOGY
9.8 RHEUMATOLOGY
9.9 OTHER APPLICATION
10 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY
10.1 OVERVIEW
10.2 ION-EXCHANGE CHROMATOGRAPHY
10.3 AFFINITY CHROMATOGRAPHY
10.4 ULTRAFILTRATION
10.5 MICROFILTRATION
10.6 CRYOPRECIPITATION
11 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY MODE
11.1 OVERVIEW
11.2 MODERN PLASMA FRACTIONATION
11.3 TRADITIONAL PLASMA FRACTIONATION
12 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS & CLINICS
12.3 CLINICAL RESEARCH LABORATORIES
12.4 ACADEMIC INSTITUTES
12.5 OTHERS
13 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 THIRD PARTY DISTRIBUTION
13.4 OTHERS
14 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY REGION
14.1 MIDDLE EAST AND AFRICA
14.1.1 SOUTH AFRICA
14.1.2 SAUDI ARABIA
14.1.3 U.A.E.
14.1.4 ISRAEL
14.1.5 EGYPT
14.1.6 REST OF MIDDLE EAST AND AFRICA
15 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 CSL PLASMA
17.1.1 COMPANY SNAPSHOT
17.1.2 COMPANY SHARE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 GRIFOLS, S.A.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 OCTAPHARMA AG
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENTS
17.4 KENDRION S.P.A
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 TAKEDA PHARMACEUTICAL COMPANY LIMITED
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 BAXTER
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 ADMA BIOLOGICS INC.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENT
17.8 BHARAT SERUMS AND VACCINES LIMITED (BSV)
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 BIO PRODUCTS LABORATORY LTD.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENT
17.1 BIOTEST AG
17.10.1 COMPANY SNAPSHOT
17.10.2 REVENUE ANALYSIS
17.10.3 PRODUCT PORTFOLIO
17.10.4 RECENT DEVELOPMENTS
17.11 BOCCARD
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 CENTURION İLAÇ SANAYI VE TICARET A.Ş.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENTS
17.14 GREEN CROSS CORP.
17.14.1 COMPANY SNAPSHOT
17.14.2 REVENUE ANALYSIS
17.14.3 PRODUCT PORTFOLIO
17.14.4 RECENT DEVELOPMENTS
17.15 INTAS PHARMACEUTICAL LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 JAPAN BLOOD PRODUCTS ORGANIZATION
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 KABAFUSION
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 LFB SA
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 MERCK KGAA
17.19.1 COMPANY SNAPSHOT
17.19.2 REVENUE ANALYSIS
17.19.3 PRODUCT PORTFOLIO
17.19.4 RECENT DEVELOPMENT
17.2 NOVASEP HOLDING SAS
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENTS
17.21 PALL CORPORATION
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 SANQUIN
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 SHANGHAI RAAS
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
17.24 SICHUAN YUANDA SHUYANG PHARMACEUTICAL CO., LTD
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENTS
17.25 SK PLASMA
17.25.1 COMPANY SNAPSHOT
17.25.2 PRODUCT PORTFOLIO
17.25.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA ALBUMIN IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA PROTEASE INHIBITORS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA OTHER PRODUCTS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, APPLICATION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA IMMUNOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA HAEMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA CRITICAL CARE IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA NEUROLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA PULMONOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA HAEMATO-ONCOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA RHEUMATOLOGY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA OTHER APPLICATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA ION-EXCHANGE CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA AFFINITY CHROMATOGRAPHY IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA ULTRAFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA MICROFILTRATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CRYOPRECIPITATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, MODE, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA MODERN PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA TRADITIONAL PLASMA FRACTIONATION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, END USER, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA HOSPITALS & CLINICS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA CLINICAL RESEARCH LABORATORIES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA ACADEMIC INSTITUTES IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA DIRECT TENDERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTION IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA OTHERS IN PLASMA FRACTIONATION MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 51 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 SOUTH AFRICA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 53 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 SAUDI ARABIA PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 U.A.E. PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 62 U.A.E. IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 63 U.A.E. COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 U.A.E. PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 U.A.E. PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 66 U.A.E. PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 67 U.A.E. PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 U.A.E. PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 69 ISRAEL PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 70 ISRAEL IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 71 ISRAEL COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 72 ISRAEL PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 ISRAEL PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 74 ISRAEL PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 75 ISRAEL PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 76 ISRAEL PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 77 EGYPT PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 78 EGYPT IMMUNOGLOBULINS IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 79 EGYPT COAGULATION FACTOR CONCENTRATES IN PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 80 EGYPT PLASMA FRACTIONATION MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 81 EGYPT PLASMA FRACTIONATION MARKET, BY PROCESSING TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 82 EGYPT PLASMA FRACTIONATION MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 83 EGYPT PLASMA FRACTIONATION MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 84 EGYPT PLASMA FRACTIONATION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 85 REST OF MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
그림 목록
FIGURE 1 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET : DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET : VENDOR SHARE ANALYSIS
FIGURE 9 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: SEGMENTATION
FIGURE 11 INCREASE IN RARE DISEASES THAT REQUIRES USE OF PLASMA THERAPY OR PLASMA DERIVATIVE IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 IMMUNOGLOBULINS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET
FIGURE 14 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, 2020
FIGURE 15 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, 2020-2028 (USD MILLION)
FIGURE 16 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, CAGR (2020-2028)
FIGURE 17 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY APPLICATION, 2020
FIGURE 19 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY APPLICATION, CAGR (2020-2028)
FIGURE 21 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, 2020
FIGURE 23 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, 2020-2028 (USD MILLION)
FIGURE 24 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, CAGR (2020-2028)
FIGURE 25 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY PROCESSING TECHNOLOGY, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY MODE, 2020
FIGURE 27 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY MODE, 2020-2028 (USD MILLION)
FIGURE 28 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY MODE, CAGR (2020-2028)
FIGURE 29 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY MODE, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY END USER, 2020
FIGURE 31 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 32 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY END USER, CAGR (2020-2028)
FIGURE 33 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 35 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 36 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)
FIGURE 37 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: SNAPSHOT (2020)
FIGURE 39 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY COUNTRY (2020)
FIGURE 40 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: BY PRODUCT TYPE (2021 & 2028)
FIGURE 43 MIDDLE EAST AND AFRICA PLASMA FRACTIONATION MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
